Wikidata

(Q42996009)

English

High rates of sustained virological response in hepatitis C virus-infected injection drug users receiving directly observed therapy with peginterferon alpha-2a (40KD) (PEGASYS) and once-daily ribavirin

scientific article published in April 2010

In more languages
default for all languages
No label defined

No description defined

Statements

title
High rates of sustained virological response in hepatitis C virus-infected injection drug users receiving directly observed therapy with peginterferon alpha-2a (40KD) (PEGASYS) and once-daily ribavirin (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20362408
retrieved
12 November 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q42996009&oldid=1976289501"